Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The fungal drug efflux system comprises membrane-bound transporter proteins that actively export antifungal agents and other toxic compounds out of fungal cells. This mechanism is a major contributor to multidrug resistance (MDR) in pathogenic fungi. Key protein families include ATP-binding cassette (ABC) transporters and major facilitator superfamily (MFS) transporters. Targeting these efflux pumps is a therapeutic strategy to combat antifungal resistance.
Active transport of antifungal agents out of fungal cells, reducing intracellular drug concentrations and enabling survival.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fungal Drug Efflux System (N/A).